These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 23111906)

  • 21. Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion.
    Bieniek KF; Murray ME; Rutherford NJ; Castanedes-Casey M; DeJesus-Hernandez M; Liesinger AM; Baker MC; Boylan KB; Rademakers R; Dickson DW
    Acta Neuropathol; 2013 Feb; 125(2):289-302. PubMed ID: 23053135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation.
    Galimberti D; Fenoglio C; Serpente M; Villa C; Bonsi R; Arighi A; Fumagalli GG; Del Bo R; Bruni AC; Anfossi M; Clodomiro A; Cupidi C; Nacmias B; Sorbi S; Piaceri I; Bagnoli S; Bessi V; Marcone A; Cerami C; Cappa SF; Filippi M; Agosta F; Magnani G; Comi G; Franceschi M; Rainero I; Giordana MT; Rubino E; Ferrero P; Rogaeva E; Xi Z; Confaloni A; Piscopo P; Bruno G; Talarico G; Cagnin A; Clerici F; Dell'Osso B; Comi GP; Altamura AC; Mariani C; Scarpini E
    Biol Psychiatry; 2013 Sep; 74(5):384-91. PubMed ID: 23473366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion.
    Brettschneider J; Van Deerlin VM; Robinson JL; Kwong L; Lee EB; Ali YO; Safren N; Monteiro MJ; Toledo JB; Elman L; McCluskey L; Irwin DJ; Grossman M; Molina-Porcel L; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2012 Jun; 123(6):825-39. PubMed ID: 22426854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts.
    Dobson-Stone C; Hallupp M; Bartley L; Shepherd CE; Halliday GM; Schofield PR; Hodges JR; Kwok JB
    Neurology; 2012 Sep; 79(10):995-1001. PubMed ID: 22875086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Jump from pre-mutation to pathologic expansion in C9orf72.
    Xi Z; van Blitterswijk M; Zhang M; McGoldrick P; McLean JR; Yunusova Y; Knock E; Moreno D; Sato C; McKeever PM; Schneider R; Keith J; Petrescu N; Fraser P; Tartaglia MC; Baker MC; Graff-Radford NR; Boylan KB; Dickson DW; Mackenzie IR; Rademakers R; Robertson J; Zinman L; Rogaeva E
    Am J Hum Genet; 2015 Jun; 96(6):962-70. PubMed ID: 26004200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unveiling New Genetic Variants Associated with Age at Onset in Alzheimer's Disease and Frontotemporal Lobar Degeneration Due to
    Longobardi A; Bellini S; Nicsanu R; Pilotto A; Geviti A; Facconi A; Tolassi C; Libri I; Saraceno C; Fostinelli S; Borroni B; Padovani A; Binetti G; Ghidoni R
    Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased risk of melanoma in C9ORF72 repeat expansion carriers: A case-control study.
    Tábuas-Pereira M; Almendra L; Almeida MR; Durães J; Pinho A; Matos A; Negrão L; Geraldo A; Santana I
    Muscle Nerve; 2019 Mar; 59(3):362-365. PubMed ID: 30447080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal fluid biomarkers for Alzheimer's disease in patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis with the C9ORF72 repeat expansion.
    Kämäläinen A; Herukka SK; Hartikainen P; Helisalmi S; Moilanen V; Knuuttila A; Jansson L; Tienari PJ; Remes AM
    Dement Geriatr Cogn Disord; 2015; 39(5-6):287-93. PubMed ID: 25791939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SLITRK2, an X-linked modifier of the age at onset in C9orf72 frontotemporal lobar degeneration.
    Barbier M; Camuzat A; Hachimi KE; Guegan J; Rinaldi D; Lattante S; Houot M; Sánchez-Valle R; Sabatelli M; Antonell A; Molina-Porcel L; Clot F; Couratier P; van der Ende E; van der Zee J; Manzoni C; Camu W; Cazeneuve C; Sellal F; Didic M; Golfier V; Pasquier F; Duyckaerts C; Rossi G; Bruni AC; Alvarez V; Gómez-Tortosa E; de Mendonça A; Graff C; Masellis M; Nacmias B; Oumoussa BM; Jornea L; Forlani S; ; Van Deerlin V; Rohrer JD; Gelpi E; Rademakers R; Van Swieten J; Le Guern E; Van Broeckhoven C; Ferrari R; Génin E; Brice A; Le Ber I
    Brain; 2021 Oct; 144(9):2798-2811. PubMed ID: 34687211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers.
    Gendron TF; van Blitterswijk M; Bieniek KF; Daughrity LM; Jiang J; Rush BK; Pedraza O; Lucas JA; Murray ME; Desaro P; Robertson A; Overstreet K; Thomas CS; Crook JE; Castanedes-Casey M; Rousseau L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; Rademakers R; Lagier-Tourenne C; Edbauer D; Cleveland DW; Dickson DW; Petrucelli L; Boylan KB
    Acta Neuropathol; 2015 Oct; 130(4):559-73. PubMed ID: 26350237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneous ribonuclear protein A3 (hnRNP A3) is present in dipeptide repeat protein containing inclusions in Frontotemporal Lobar Degeneration and Motor Neurone disease associated with expansions in C9orf72 gene.
    Davidson YS; Flood L; Robinson AC; Nihei Y; Mori K; Rollinson S; Richardson A; Benson BC; Jones M; Snowden JS; Pickering-Brown S; Haass C; Lashley T; Mann DMA
    Acta Neuropathol Commun; 2017 Apr; 5(1):31. PubMed ID: 28431575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions.
    Simón-Sánchez J; Dopper EG; Cohn-Hokke PE; Hukema RK; Nicolaou N; Seelaar H; de Graaf JR; de Koning I; van Schoor NM; Deeg DJ; Smits M; Raaphorst J; van den Berg LH; Schelhaas HJ; De Die-Smulders CE; Majoor-Krakauer D; Rozemuller AJ; Willemsen R; Pijnenburg YA; Heutink P; van Swieten JC
    Brain; 2012 Mar; 135(Pt 3):723-35. PubMed ID: 22300876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral inflammatory markers and clinical correlations in patients with frontotemporal lobar degeneration with and without the C9orf72 repeat expansion.
    Katisko K; Solje E; Korhonen P; Jääskeläinen O; Loppi S; Hartikainen P; Koivisto AM; Kontkanen A; Korhonen VE; Helisalmi S; Malm T; Herukka SK; Remes AM; Haapasalo A
    J Neurol; 2020 Jan; 267(1):76-86. PubMed ID: 31559531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased prevalence of granulovacuolar degeneration in C9orf72 mutation.
    Riku Y; Duyckaerts C; Boluda S; Plu I; Le Ber I; Millecamps S; Salachas F; ; Yoshida M; Ando T; Katsuno M; Sobue G; Seilhean D
    Acta Neuropathol; 2019 Nov; 138(5):783-793. PubMed ID: 31144027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-incidental C9orf72 expansion mutation-related frontotemporal lobar degeneration pathology and sporadic Creutzfeldt-Jakob disease.
    Klotz S; König T; Erdler M; Ulram A; Nguyen A; Ströbel T; Zimprich A; Stögmann E; Regelsberger G; Höftberger R; Budka H; Kovacs GG; Gelpi E
    Eur J Neurol; 2021 Mar; 28(3):1009-1015. PubMed ID: 33131137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of C9orf72 Intermediate Alleles in a Retrospective Cohort of Neurological Patients: Risk Factors for Alzheimer's Disease?
    Serpente M; Fenoglio C; Arighi A; Fumagalli GG; Arcaro M; Sorrentino F; Visconte C; Scarpini E; Galimberti D
    J Alzheimers Dis; 2021; 81(4):1445-1451. PubMed ID: 33935096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
    Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
    Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The neuropathology associated with repeat expansions in the C9ORF72 gene.
    Mackenzie IR; Frick P; Neumann M
    Acta Neuropathol; 2014 Mar; 127(3):347-57. PubMed ID: 24356984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum neurofilament light chain in FTLD: association with C9orf72, clinical phenotype, and prognosis.
    Cajanus A; Katisko K; Kontkanen A; Jääskeläinen O; Hartikainen P; Haapasalo A; Herukka SK; Vanninen R; Solje E; Hall A; Remes AM
    Ann Clin Transl Neurol; 2020 Jun; 7(6):903-910. PubMed ID: 32441885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C9orf72 isoforms in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration.
    Xiao S; MacNair L; McLean J; McGoldrick P; McKeever P; Soleimani S; Keith J; Zinman L; Rogaeva E; Robertson J
    Brain Res; 2016 Sep; 1647():43-49. PubMed ID: 27134035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.